ARCHIVES

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975